RTW INVESTMENTS, LP Q2 2016 Filing
Filed August 15, 2016
Portfolio Value
$292.7B
Holdings
35
Report Date
Q2 2016
Filing Type
13F-HR
All Holdings (35 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ALNYAlnylam Pharmaceuticals Inc | 832,549 | $46.2B | 15.78% | |
| 2 | INCYIncyte Corp | 392,236 | $31.4B | 10.72% | |
| 3 | —bluebird bio Inc | 612,025 | $26.5B | 9.05% | |
| 4 | —Achillion Pharmaceuticals Inc | 2,424,136 | $18.9B | 6.46% | |
| 5 | —La Jolla Pharmaceutical Co | 1,176,146 | $18.8B | 6.43% | |
| 6 | —Avexis Inc | 476,367 | $18.1B | 6.19% | |
| 7 | BMYBristol-Myers Squibb Co | 209,701 | $15.4B | 5.27% | |
| 8 | —Kite Pharma Inc | 285,518 | $14.3B | 4.88% | |
| 9 | —Symmetry Surgical Inc | 922,215 | $12.1B | 4.14% | |
| 10 | GQ9SPDR Gold Shares ETF | 83,000 | $10.5B | 3.59% | |
| 11 | ATRAGBXAtara Biotherapeutics Inc. | 465,874 | $10.5B | 3.58% | |
| 12 | AGENEURAgenus Inc | 2,429,149 | $9.8B | 3.36% | |
| 13 | BCRXBioCryst Pharmaceuticals Inc | 2,237,066 | $6.4B | 2.17% | |
| 14 | TLTiShares 20+ Year Treasury Bond ETF | 45,000 | $6.3B | 2.14% | |
| 15 | —Dicerna Pharmaceuticals Inc | 2,026,894 | $6.1B | 2.08% | |
| 16 | ICPTUSDIntercept Pharmaceuticals Inc | 39,500 | $5.6B | 1.93% | |
| 17 | —Celldex Therapeutics Inc | 1,264,227 | $5.5B | 1.90% | |
| 18 | OMEROmeros Corp | 526,788 | $5.5B | 1.89% | |
| 19 | —Viveve Medical Inc | 814,946 | $3.3B | 1.14% | |
| 20 | —Barclays Bank iPath Dow Jones-UBS Coffee Subindex TR ETN | 144,200 | $3.2B | 1.09% | |
| 21 | —Corium International Inc | 852,961 | $3.0B | 1.01% | |
| 22 | —Invuity Inc | 226,042 | $2.2B | 0.74% | |
| 23 | RGNXRegenxbio Inc | 242,784 | $1.9B | 0.66% | |
| 24 | —Five Prime Therapeutics Inc | 44,701 | $1.8B | 0.63% | |
| 25 | GBTUSDGlobal Blood Therapeutics Inc | 97,138 | $1.6B | 0.55% | |
| 26 | 3M4Masimo Corp | 25,900 | $1.4B | 0.46% | |
| 27 | —Accelerate Diagnostics Inc | 74,843 | $1.1B | 0.37% | |
| 28 | —CytRx Corp | 466,200 | $1.0B | 0.36% | |
| 29 | —Sensus Healthcare Inc | 155,000 | $1.0B | 0.34% | |
| 30 | —MNKD 01/20/2017 PUT 3 | 4,385 | $912.0M | 0.31% | Put |
| 31 | MRTXEURMirati Therapeutics Inc | 131,052 | $716.0M | 0.24% | |
| 32 | MDRXAllscripts Healthcare Solutions Inc | 48,000 | $610.0M | 0.21% | |
| 33 | —Biopharmx Corp | 700,636 | $455.0M | 0.16% | |
| 34 | NTRANatera Inc | 31,693 | $382.0M | 0.13% | |
| 35 | —Nivalis Therapeutics Inc | 30,000 | $138.0M | 0.05% |